A new genetics project could help “unlock a series of secrets about devastating diseases”, the NHS says.
Under the scheme, 11 Genomics Medicine Centres are being set up in English hospitals to gather DNA samples to help devise targeted treatments for a wide range of diseases.
It is focusing on cancer and rare genetic diseases.
The aim is to sequence 100,000 genomes within three years in order to develop new tests and drugs.
Doctors will offer suitable patients the opportunity to take part in the scheme.
They will have to agree to have their genetic code and medical records – stripped of anything that could identify them – made available to drugs companies and researchers.
Up to 25,000 cancer patients will have the genetic code of their healthy tissue compared to the genetic code of their tumour.
A giant game of spot-the-difference will then take place to identify the precise mutations in DNA that are causing a patient’s tumour.
This would allow targeted medicines to be developed.
Previous genetics research has shown how different cancers can be – for example that breast cancer is not one disease but at least 10 – each with a different cause and life expectancy and each needing a different treatment.
And the development of targeted drugs such as Herceptin – given only if a patient’s breast tumour has a certain mutation – has been possible because of genetics research.
Meanwhile, 15,000 patients with rare diseases will have their genome compared with those of their parents and grandparents.
Thousands of genetic diseases – which are individually rare but combined affect large numbers of people – could be identified by finding mistakes in the three billion pairs of letters that make up our genetic code.
The resulting knowledge could give patients an explanation for a disease that has plagued their entire life.
Prof Graeme Black, who will lead the project in Manchester, told the BBC: “It’s possible to sequence an individual’s entire genetic make-up, their genome, in merely a few days where five years ago that was completely unimaginable.
Read more: NHS DNA scheme to fight cancer and genetic diseases
The Latest on: Genomics Medicine Centres
[google_news title=”” keyword=”Genomics Medicine Centres” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Genomics Medicine Centres
- Genomics Are a Lifesaver for Patients With Rare Diseaseson June 7, 2023 at 4:00 am
says Nicola Blackwood, chair of Genomics England, the UK-government-owned company that runs the 100,000 Genomes Project. Currently, around 5,000 patients a month use the service, not just for rare ...
- Gene Prediction Tools Market is likely to register CAGR of 18.3% through 2033on June 5, 2023 at 7:12 pm
In 2023, the Gene Prediction Tools Market size is expected to be worth US$ 127.3 million. The market is expected to reach US$ 680.9 million by 2033, expanding at an 18.3% CAGR throughout the forecast ...
- Element Enters the European Genomics Market with New Customers and a Growing Teamon June 5, 2023 at 4:08 am
A year after launching the AVITI System, Element has completed successful installations across the United States, Asia and now Europe. With the establishment of a European entity and a growing sales ...
- Home Minister Amit Shah inaugurates Amrita Hospitals’ two new research centreson June 4, 2023 at 10:23 am
Union Home Minister Amit Shah speaks after inaugurating the two new research centres of Amrita Hospitals They say the answers to the greatest mysteries lie within us. Ironically, both experts in ...
- Vancouver Prostate Centre is leading research on men’s health, prostate canceron June 2, 2023 at 11:14 am
UBC Faculty of Medicine researchers at the Vancouver Prostate Centre (VPC) have investigated the detection, diagnosis and treatment of prostate cancer.
- Illumina's (ILMN) New AI Tool to Predict Genomics Diseaseon June 1, 2023 at 5:44 pm
PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.
- Antioxidant Enzymes Come to the Rescue of DNA Damageon June 1, 2023 at 5:21 pm
The team experimentally induced DNA damage in human cell lines using a common chemotherapy medication known as etoposide. They observed that cellular respiratory enzymes relocated from the ...
- Genomics Global Market Report 2023: Potential for Brand New Therapeutic and Research Applications Presents Opportunitieson May 30, 2023 at 3:03 am
Global Genomics Market Global Genomics Market Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Genomics Market Size, Share & Trends Analysis Report By Technology & Application (Functional Genomics, ...
- World of Genomics: Ghanaon May 30, 2023 at 12:59 am
Indeed, Ghana is a multi-ethnic country, as shown by the fact that approximately eighty languages are spoken by its population. To this day, the full extent of Ghana’s history isn’t entirely known; it ...
- Genomics England partners with Seqera Labs to improve NHS cancer careon May 29, 2023 at 8:04 am
Government-owned company Genomics England has partnered with bioinformatics firm Segera Labs to advance cancer care in the NHS.
via Bing News